9.1 Severe Dysnatremias: Hyponatremia, Hypernatremia & Osmotic Demyelination

Diagnostic Classification and Tonicity Framework

Dysnatremias are disorders of water homeostasis, not total body sodium content. Serum sodium concentration reflects the ratio of total exchangeable sodium and potassium to total body water (the Edelman equation):

$\text{Serum } [\text{Na}^+] \approx \frac{\text{Exchangeable } \text{Na}^+ + \text{Exchangeable } \text{K}^+}{\text{Total Body Water}}$

Hyponatremia ($[\text{Na}^+] < 135\text{ mEq/L}$) represents the most prevalent electrolyte abnormality encountered in the intensive care unit (ICU). A disciplined diagnostic approach requires determining effective serum osmolality (tonicity), followed by clinical extracellular fluid (ECF) volume status and urinary biochemical indices.

Loading diagram...

1. Tonicity Stratification

• Hypertonic Hyponatremia ($S_{\text{Osm}} > 295\text{ mOsm/kg}$): Occurs when impermeant, non-sodium solutes accumulate in the extracellular compartment, generating an osmotic gradient that shifts water out of intracellular space into the vascular bed, diluting serum sodium. The primary etiology is profound hyperglycemia (diabetic ketoacidosis or hyperosmolar hyperglycemic state), as well as intravenous mannitol, sorbitol, or maltose infusions (used in IV immunoglobulin formulations).
  • Katz Correction Formula: For every $100\text{ mg/dL}$ rise in blood glucose above $100\text{ mg/dL}$, measured serum sodium decreases by approximately $1.6\text{ mEq/L}$: $\text{Corrected } [\text{Na}^+] = \text{Measured } [\text{Na}^+] + 0.016 \times (\text{Glucose} - 100)$
  • Hillier Correction Formula: In marked hyperglycemia ($> 400\text{ mg/dL}$), a correction factor of $2.4\text{ mEq/L}$ per $100\text{ mg/dL}$ glucose rise provides superior physiologic precision: $\text{Corrected } [\text{Na}^+] = \text{Measured } [\text{Na}^+] + 0.024 \times (\text{Glucose} - 100)$
• Isotonic Pseudohyponatremia ($S_{\text{Osm}} = 275\text{ to }295\text{ mOsm/kg}$): An artifact of laboratory measurement occurring with indirect potentiometry (flame photometry or indirect ion-selective electrodes [ISE]). In normal serum, plasma water comprises 93% of total volume, with solids (lipids and proteins) accounting for the remaining 7%. Extreme hypertriglyceridemia (chylomicronemia $> 1500\text{ mg/dL}$) or extreme paraproteinemia (multiple myeloma, Waldenström macroglobulinemia, high-dose IVIG) expands the solid non-aqueous phase to 15-20%. Because indirect ISE dilutes the sample before measurement assuming a standard 93% aqueous fraction, sodium concentration is falsely reported as low despite normal active sodium concentration in the aqueous phase. Direct ISE (such as on point-of-care arterial blood gas analyzers) measures undiluted plasma water and is immune to pseudohyponatremia.
• Hypotonic Hyponatremia ($S_{\text{Osm}} < 275\text{ mOsm/kg}$): True hyponatremia characterized by relative excess of free water over sodium.

---

Hypotonic Hyponatremia: Volume Classification and Diagnostic Indices

Once true hypotonic hyponatremia is confirmed, physical examination of extracellular fluid volume coupled with urine osmolality ($U_{\text{Osm}}$) and spot urine sodium ($U_{\text{Na}}$) establishes the underlying etiology:

SIADH Diagnostic Criteria (Bartter-Schwartz Criteria)

The Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) requires:

1. Hypotonic hyponatremia ($S_{\text{Osm}} < 275\text{ mOsm/kg}$);
2. Inappropriate urinary concentration ($U_{\text{Osm}} > 100\text{ mOsm/kg}$, frequently $> 300-500\text{ mOsm/kg}$);
3. Inappropriate natriuresis ($U_{\text{Na}} > 30-40\text{ mEq/L}$) in the setting of standard dietary sodium and fluid intake;
4. Strict clinical euvolemia (absence of peripheral edema, ascites, or orthostatic hypovolemia);
5. Normal thyroid and adrenal function (euthyroid, eucortisolemic);
6. Absence of recent diuretic exposure.

SIADH vs. Cerebral Salt Wasting (CSW)

In neurosurgical and neurocritical care patients (e.g., subarachnoid hemorrhage, severe traumatic brain injury, intracranial neoplasms), distinguishing SIADH from CSW is critical because their treatments are diametrically opposed:

---

Acute Symptomatic Hyponatremia: Neurocritical Emergency Protocol

Acute hyponatremia develops over $< 48\text{ hours}$, preventing the brain from extruding intracellular organic osmolytes. The osmotic gradient drives water into glial cells and neurons, producing acute cerebral edema, elevated intracranial pressure (ICP), tentorial herniation, respiratory arrest, status epilepticus, and death.

Loading diagram...

Hypertonic Saline Resuscitation Protocol

1. Immediate Bolus Therapy: For severe neurological manifestations (coma, generalized seizures, stupor, respiratory depression), administer $100\text{ to }150\text{ mL}$ of $3\%$ hypertonic saline IV over $10\text{ minutes}$ (or $2\text{ mL/kg}$ in non-standard weights).
2. Repeat Dosing: If neurological symptoms persist, repeat the $100\text{ to }150\text{ mL}$ bolus every 10 to 20 minutes, up to a maximum of three total boluses.
3. Therapeutic Target: The immediate objective is NOT normalization of serum sodium. An acute elevation of $4\text{ to }6\text{ mEq/L}$ reduces brain volume by approximately 5%, which is sufficient to reduce ICP, reverse brainstem displacement, and abort status epilepticus.
4. Discontinuation: Once symptoms resolve or serum sodium increases by $4\text{ to }6\text{ mEq/L}$, active hypertonic saline infusions must cease immediately.

---

Osmotic Demyelination Syndrome (ODS) and Correction Boundaries

In chronic hyponatremia ($> 48\text{ hours}$ duration), brain cells undergo osmotic adaptation. During the initial 24 to 48 hours, astrocytes extrude inorganic ions ($\text{Na}^+, \text{K}^+, \text{Cl}^-$) followed by organic osmolytes (myo-inositol, glutamate, taurine, betaine, glutamine) to restore baseline cell volume. While this protects against cerebral edema, it leaves astrocytes vulnerable to dehydration if extracellular tonicity is corrected rapidly.

Pathophysiology and Clinical Presentation of ODS

When chronic hypotonic serum is corrected too rapidly, extracellular tonicity outpaces the slow re-synthesis and re-accumulation of organic osmolytes (which requires several days). Astrocytes dehydrate, undergo apoptotic lysis, disrupt the blood-brain barrier, and trigger non-inflammatory demyelination. The high metabolic activity and crisscrossing white-matter architecture of the pons make it especially vulnerable (Central Pontine Myelinolysis), though extrapontine structures (basal ganglia, thalamus, internal capsules) may also be affected.

• Biphasic Course: The patient initially improves as acute encephalopathy clears, followed 2 to 6 days later by progressive, catastrophic neurological decline.
• Clinical Manifestations: Spastic quadriparesis, pseudobulbar palsy (dysphagia, dysarthria), mutism, ataxia, and classical "locked-in syndrome" (preserved vertical eye movements and consciousness with complete paralysis of all voluntary motor function). ODS is largely irreversible and carries devastating morbidity.

Absolute Correction Limits

• Goal for All Chronic Hyponatremia: A minimum correction of $4\text{ to }8\text{ mEq/L}$ per 24 hours (4-6 mEq/L is often enough to relieve symptoms).
• Standard-Risk Patients: The 2013 US expert panel limit is $10\text{ to }12\text{ mEq/L}$ in any 24-hour period and $18\text{ mEq/L}$ in 48 hours; the 2014 European guideline uses a limit of 10 mEq/L in the first 24 hours and 8 mEq/L in each subsequent 24 hours. Many ICUs simply treat 8 mEq/L per day as the working ceiling.
• High-Risk Patients: Serum sodium $\le 105\text{ mEq/L}$, hypokalemia, alcohol use disorder, malnutrition, or advanced liver disease (including the peri-liver-transplant period). In these patients:
  • Target correction rate: $4\text{ to }6\text{ mEq/L}$ per 24 hours;
  • Limit: $8\text{ mEq/L}$ in any 24-hour period.

Management of Overcorrection: The Desmopressin (DDAVP) Clamp

When serum sodium correction exceeds the limit (or threatens to exceed it, especially in high-risk patients), therapeutic re-lowering should be started promptly to reduce the risk of osmotic demyelination:

1. Rescue Re-lowering Protocol:
   • Discontinue all hypertonic fluids, isotonic crystalloids, and salt supplements;
   • Administer intravenous $5\%$ dextrose in water (D5W) at $3\text{ to }5\text{ mL/kg/h}$;
   • Administer Desmopressin (DDAVP) $1\text{ to }2\text{ mcg}$ IV or SQ every 6 to 8 hours to activate renal V2 receptors, halt aquaresis, and re-concentrate the urine;
   • Serial sodium measurements every 2 hours until the serum sodium concentration returns to the target threshold ($6\text{ to }8\text{ mEq/L}$ above starting baseline).
2. Proactive DDAVP Clamp Strategy: In patients with profound chronic hyponatremia ($< 115\text{ mEq/L}$), DDAVP ($1-2\text{ mcg}$ IV q8h) is administered concurrently with $3\%$ hypertonic saline from the start of therapy. This "locks" the renal collecting duct, preventing unexpected spontaneous aquaresis and allowing the clinician to control the rate of sodium elevation using titrated $3\%$ saline.

---

Hypernatremia and Free Water Deficit Calculation

Hypernatremia ($[\text{Na}^+] > 145\text{ mEq/L}$, severe $> 155-160\text{ mEq/L}$) always indicates hypertonicity and cellular dehydration. Intact thirst mechanisms normally protect against hypernatremia; therefore, severe hypernatremia in the ICU occurs almost exclusively in patients with impaired thirst, altered sensorium, intubated/sedated states, or restricted access to free water.

Free Water Deficit (FWD) Formula

To restore serum sodium to normal, the clinician must quantify the absolute free water deficit:

$\text{FWD} = \text{Total Body Water (TBW)} \times \left(\frac{\text{Serum }[\text{Na}^+]}{140} - 1\right)$

Where Total Body Water (TBW) is calculated based on age and sex:

• Young males: $\text{Weight (kg)} \times 0.6$
• Young females or elderly males: $\text{Weight (kg)} \times 0.5$
• Elderly females: $\text{Weight (kg)} \times 0.45$

Worked Example

A 70 kg, 72-year-old male with severe dehydration and altered mental status has a serum sodium of $165\text{ mEq/L}$.

1. Calculate baseline TBW: $\text{TBW} = 70\text{ kg} \times 0.5 = 35\text{ L}$
2. Calculate the Free Water Deficit: $\text{FWD} = 35 \times \left(\frac{165}{140} - 1\right) = 35 \times (1.1786 - 1) = 35 \times 0.1786 \approx 6.25\text{ Liters}$
3. Accounting for ongoing insensible losses (sweat, respiration $\approx 30-50\text{ mL/h} = 800-1200\text{ mL/day}$) and ongoing urinary free water losses, total required water replacement over 48 hours is approximately $8.5\text{ Liters}$.

Correction Rate Limits in Hypernatremia

During chronic hypernatremia ($> 48\text{ hours}$), brain cells accumulate idiogenic osmoles (organic solutes such as taurine, myo-inositol, and amino acids) to preserve cell volume against the hypertonic extracellular environment. If free water is administered too rapidly, water rushes into brain cells along the osmotic gradient, triggering iatrogenic cerebral edema, seizures, permanent neurological injury, and death.

---

Polyuric Syndromes: Central vs. Nephrogenic Diabetes Insipidus

Diabetes insipidus (DI) is characterized by the excretion of large volumes of dilute urine ($> 3\text{ L/24h}$ or $> 40-50\text{ mL/kg/24h}$ with $U_{\text{Osm}} < 300\text{ mOsm/kg}$). When fluid intake does not match urinary losses, severe hypernatremia ensues.

Loading diagram...

Central (Neurogenic) Diabetes Insipidus

• Etiologies: Traumatic brain injury, transsphenoidal pituitary surgery, severe hypoxic-ischemic brain injury, intracranial mass lesions, lymphocytic hypophysitis, brain death. In pituitary surgery, a classic triphasic response may occur:
  1. Phase 1 (Days 1-2): Acute DI from hypothalamic/pituitary shock (polyuria, hypernatremia);
  2. Phase 2 (Days 3-7): Transient SIADH from uncontrolled leak of preformed ADH from degenerating posterior pituitary axons (oliguria, hyponatremia);
  3. Phase 3 (Day 8+): Permanent DI once hormone stores are depleted.
• Desmopressin Challenge: Exogenous desmopressin ($1-2\text{ mcg}$ IV or $10\text{ mcg}$ intranasal) elicits a $> 50\%$ (frequently $> 100-200\%$) increase in urine osmolality, accompanied by a dramatic reduction in hourly urine volume.
• Treatment: Desmopressin titrated to maintain urine output at $1.5\text{ to }2.0\text{ L/day}$, combined with free water replacement via enteral tube or IV D5W.

Nephrogenic Diabetes Insipidus

• Etiologies: Chronic lithium therapy (downregulates aquaporin-2 water channels in principal cells), severe hypercalcemia, severe hypokalemia, demeclocycline, amphotericin B, foscarnet, relief of bilateral urinary tract obstruction, sickle cell nephropathy.
• Desmopressin Challenge: Exogenous desmopressin produces no significant response (urine osmolality rises by $< 50\%$, often $< 10\%$).
• Treatment: Discontinuation of offending drugs; low-sodium, low-protein diet to decrease renal solute load; thiazide diuretics (induce mild volume depletion, promoting proximal tubular sodium and water reabsorption and reducing water delivery to the collecting duct); amiloride (blocks apical epithelial sodium channels [ENaC], specifically blocking lithium entry into principal cells in lithium-induced NDI); indomethacin (inhibits prostaglandin synthesis, enhancing medullary concentrating capacity).